United States Therapeutic Drug Monitoring Market Report 2017
Notes:
Sales, means the sales volume of Therapeutic Drug Monitoring
Revenue, means the sales value of Therapeutic Drug Monitoring
This report studies sales (consumption) of Therapeutic Drug Monitoring in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sales, means the sales volume of Therapeutic Drug Monitoring
Revenue, means the sales value of Therapeutic Drug Monitoring
This report studies sales (consumption) of Therapeutic Drug Monitoring in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
- F. Hoffmann-La Roche AG
- Siemens Healthcare
- Thermo Fisher Scientific
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- California
- Texas
- New York
- Florida
- Illinois
- Blood test
- Urine test
- Saliva test
- Other test
- Hospital Laboratories
- Commercial/Private Laboratories
- Others
United States Therapeutic Drug Monitoring Market Report 2017
1 THERAPEUTIC DRUG MONITORING OVERVIEW
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring
1.2.1 Blood test
1.2.2 Urine test
1.2.3 Saliva test
1.2.4 Other test
1.3 Application of Therapeutic Drug Monitoring
1.3.1 Hospital Laboratories
1.3.2 Commercial/Private Laboratories
1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Therapeutic Drug Monitoring (2011-2021)
1.4.1 United States Therapeutic Drug Monitoring Sales and Growth Rate (2011-2021)
1.4.2 United States Therapeutic Drug Monitoring Revenue and Growth Rate (2011-2021)
2 UNITED STATES THERAPEUTIC DRUG MONITORING COMPETITION BY MANUFACTURERS
2.1 United States Therapeutic Drug Monitoring Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Therapeutic Drug Monitoring Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Therapeutic Drug Monitoring Average Price by Manufactures (2015 and 2016)
2.4 Therapeutic Drug Monitoring Market Competitive Situation and Trends
2.4.1 Therapeutic Drug Monitoring Market Concentration Rate
2.4.2 Therapeutic Drug Monitoring Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)
3.1 United States Therapeutic Drug Monitoring Sales and Market Share by States (2011-2016)
3.2 United States Therapeutic Drug Monitoring Revenue and Market Share by States (2011-2016)
3.3 United States Therapeutic Drug Monitoring Price by States (2011-2016)
4 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)
4.1 United States Therapeutic Drug Monitoring Sales and Market Share by Type (2011-2016)
4.2 United States Therapeutic Drug Monitoring Revenue and Market Share by Type (2011-2016)
4.3 United States Therapeutic Drug Monitoring Price by Type (2011-2016)
4.4 United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2011-2016)
5 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) BY APPLICATION (2011-2016)
5.1 United States Therapeutic Drug Monitoring Sales and Market Share by Application (2011-2016)
5.2 United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities
6 UNITED STATES THERAPEUTIC DRUG MONITORING MANUFACTURERS PROFILES/ANALYSIS
6.1 F. Hoffmann-La Roche AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.1.2.1 Blood test
6.1.2.2 Urine test
6.1.3 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthcare
6.2.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.2.2.1 Blood test
6.2.2.2 Urine test
6.2.3 Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific
6.3.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.3.2.1 Blood test
6.3.2.2 Urine test
6.3.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Bio-Rad Laboratories Inc.
6.4.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.4.2.1 Blood test
6.4.2.2 Urine test
6.4.3 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Danaher Corporation
6.5.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.5.2.1 Blood test
6.5.2.2 Urine test
6.5.3 Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
7 THERAPEUTIC DRUG MONITORING MANUFACTURING COST ANALYSIS
7.1 Therapeutic Drug Monitoring Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Drug Monitoring
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Therapeutic Drug Monitoring Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2015
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES THERAPEUTIC DRUG MONITORING MARKET FORECAST (2016-2021)
11.1 United States Therapeutic Drug Monitoring Sales, Revenue Forecast (2016-2021)
11.2 United States Therapeutic Drug Monitoring Sales Forecast by Type (2016-2021)
11.3 United States Therapeutic Drug Monitoring Sales Forecast by Application (2016-2021)
11.4 Therapeutic Drug Monitoring Price Forecast (2016-2021)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 THERAPEUTIC DRUG MONITORING OVERVIEW
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring
1.2.1 Blood test
1.2.2 Urine test
1.2.3 Saliva test
1.2.4 Other test
1.3 Application of Therapeutic Drug Monitoring
1.3.1 Hospital Laboratories
1.3.2 Commercial/Private Laboratories
1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Therapeutic Drug Monitoring (2011-2021)
1.4.1 United States Therapeutic Drug Monitoring Sales and Growth Rate (2011-2021)
1.4.2 United States Therapeutic Drug Monitoring Revenue and Growth Rate (2011-2021)
2 UNITED STATES THERAPEUTIC DRUG MONITORING COMPETITION BY MANUFACTURERS
2.1 United States Therapeutic Drug Monitoring Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Therapeutic Drug Monitoring Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Therapeutic Drug Monitoring Average Price by Manufactures (2015 and 2016)
2.4 Therapeutic Drug Monitoring Market Competitive Situation and Trends
2.4.1 Therapeutic Drug Monitoring Market Concentration Rate
2.4.2 Therapeutic Drug Monitoring Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)
3.1 United States Therapeutic Drug Monitoring Sales and Market Share by States (2011-2016)
3.2 United States Therapeutic Drug Monitoring Revenue and Market Share by States (2011-2016)
3.3 United States Therapeutic Drug Monitoring Price by States (2011-2016)
4 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)
4.1 United States Therapeutic Drug Monitoring Sales and Market Share by Type (2011-2016)
4.2 United States Therapeutic Drug Monitoring Revenue and Market Share by Type (2011-2016)
4.3 United States Therapeutic Drug Monitoring Price by Type (2011-2016)
4.4 United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2011-2016)
5 UNITED STATES THERAPEUTIC DRUG MONITORING SALES (VOLUME) BY APPLICATION (2011-2016)
5.1 United States Therapeutic Drug Monitoring Sales and Market Share by Application (2011-2016)
5.2 United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities
6 UNITED STATES THERAPEUTIC DRUG MONITORING MANUFACTURERS PROFILES/ANALYSIS
6.1 F. Hoffmann-La Roche AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.1.2.1 Blood test
6.1.2.2 Urine test
6.1.3 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthcare
6.2.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.2.2.1 Blood test
6.2.2.2 Urine test
6.2.3 Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific
6.3.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.3.2.1 Blood test
6.3.2.2 Urine test
6.3.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Bio-Rad Laboratories Inc.
6.4.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.4.2.1 Blood test
6.4.2.2 Urine test
6.4.3 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Danaher Corporation
6.5.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.5.2.1 Blood test
6.5.2.2 Urine test
6.5.3 Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
7 THERAPEUTIC DRUG MONITORING MANUFACTURING COST ANALYSIS
7.1 Therapeutic Drug Monitoring Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Drug Monitoring
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Therapeutic Drug Monitoring Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2015
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES THERAPEUTIC DRUG MONITORING MARKET FORECAST (2016-2021)
11.1 United States Therapeutic Drug Monitoring Sales, Revenue Forecast (2016-2021)
11.2 United States Therapeutic Drug Monitoring Sales Forecast by Type (2016-2021)
11.3 United States Therapeutic Drug Monitoring Sales Forecast by Application (2016-2021)
11.4 Therapeutic Drug Monitoring Price Forecast (2016-2021)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Picture of Therapeutic Drug Monitoring
Table Classification of Therapeutic Drug Monitoring
Figure United States Sales Market Share of Therapeutic Drug Monitoring by Type in 2015
Figure Blood test Picture
Figure Urine test Picture
Figure Saliva test Picture
Figure Other test Picture
Table Application of Therapeutic Drug Monitoring
Figure United States Sales Market Share of Therapeutic Drug Monitoring by Application in 2015
Figure Hospital Laboratories Examples
Figure Commercial/Private Laboratories Examples
Figure Others Examples
Figure United States Therapeutic Drug Monitoring Sales and Growth Rate (2011-2021)
Figure United States Therapeutic Drug Monitoring Revenue and Growth Rate (2011-2021)
Table United States Therapeutic Drug Monitoring Sales of Key Manufacturers (2015 and 2016)
Table United States Therapeutic Drug Monitoring Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Therapeutic Drug Monitoring Sales Share by Manufacturers
Figure 2016 Therapeutic Drug Monitoring Sales Share by Manufacturers
Table United States Therapeutic Drug Monitoring Revenue by Manufacturers (2015 and 2016)
Table United States Therapeutic Drug Monitoring Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Therapeutic Drug Monitoring Revenue Share by Manufacturers
Table 2016 United States Therapeutic Drug Monitoring Revenue Share by Manufacturers
Table United States Market Therapeutic Drug Monitoring Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Therapeutic Drug Monitoring Average Price of Key Manufacturers in 2015
Figure Therapeutic Drug Monitoring Market Share of Top 3 Manufacturers
Figure Therapeutic Drug Monitoring Market Share of Top 5 Manufacturers
Table United States Therapeutic Drug Monitoring Sales by States (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Share by States (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by States in 2015
Table United States Therapeutic Drug Monitoring Revenue and Market Share by States (2011-2016)
Table United States Therapeutic Drug Monitoring Revenue Share by States (2011-2016)
Figure Revenue Market Share of Therapeutic Drug Monitoring by States (2011-2016)
Table United States Therapeutic Drug Monitoring Price by States (2011-2016)
Table United States Therapeutic Drug Monitoring Sales by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Share by Type (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Type in 2015
Table United States Therapeutic Drug Monitoring Revenue and Market Share by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Price by Type (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Sales by Application (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Market Share by Application (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Application in 2015
Table United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Bio-Rad Laboratories Inc. Basic Information List
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Danaher Corporation Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Drug Monitoring
Figure Manufacturing Process Analysis of Therapeutic Drug Monitoring
Figure Therapeutic Drug Monitoring Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2015
Table Major Buyers of Therapeutic Drug Monitoring
Table Distributors/Traders List
Figure United States Therapeutic Drug Monitoring Production and Growth Rate Forecast (2016-2021)
Figure United States Therapeutic Drug Monitoring Revenue and Growth Rate Forecast (2016-2021)
Table United States Therapeutic Drug Monitoring Production Forecast by Type (2016-2021)
Table United States Therapeutic Drug Monitoring Consumption Forecast by Application (2016-2021)
Table United States Therapeutic Drug Monitoring Sales Forecast by States (2016-2021)
Table United States Therapeutic Drug Monitoring Sales Share Forecast by States (2016-2021)
Figure Picture of Therapeutic Drug Monitoring
Table Classification of Therapeutic Drug Monitoring
Figure United States Sales Market Share of Therapeutic Drug Monitoring by Type in 2015
Figure Blood test Picture
Figure Urine test Picture
Figure Saliva test Picture
Figure Other test Picture
Table Application of Therapeutic Drug Monitoring
Figure United States Sales Market Share of Therapeutic Drug Monitoring by Application in 2015
Figure Hospital Laboratories Examples
Figure Commercial/Private Laboratories Examples
Figure Others Examples
Figure United States Therapeutic Drug Monitoring Sales and Growth Rate (2011-2021)
Figure United States Therapeutic Drug Monitoring Revenue and Growth Rate (2011-2021)
Table United States Therapeutic Drug Monitoring Sales of Key Manufacturers (2015 and 2016)
Table United States Therapeutic Drug Monitoring Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Therapeutic Drug Monitoring Sales Share by Manufacturers
Figure 2016 Therapeutic Drug Monitoring Sales Share by Manufacturers
Table United States Therapeutic Drug Monitoring Revenue by Manufacturers (2015 and 2016)
Table United States Therapeutic Drug Monitoring Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Therapeutic Drug Monitoring Revenue Share by Manufacturers
Table 2016 United States Therapeutic Drug Monitoring Revenue Share by Manufacturers
Table United States Market Therapeutic Drug Monitoring Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Therapeutic Drug Monitoring Average Price of Key Manufacturers in 2015
Figure Therapeutic Drug Monitoring Market Share of Top 3 Manufacturers
Figure Therapeutic Drug Monitoring Market Share of Top 5 Manufacturers
Table United States Therapeutic Drug Monitoring Sales by States (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Share by States (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by States in 2015
Table United States Therapeutic Drug Monitoring Revenue and Market Share by States (2011-2016)
Table United States Therapeutic Drug Monitoring Revenue Share by States (2011-2016)
Figure Revenue Market Share of Therapeutic Drug Monitoring by States (2011-2016)
Table United States Therapeutic Drug Monitoring Price by States (2011-2016)
Table United States Therapeutic Drug Monitoring Sales by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Share by Type (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Type in 2015
Table United States Therapeutic Drug Monitoring Revenue and Market Share by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Price by Type (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Type (2011-2016)
Table United States Therapeutic Drug Monitoring Sales by Application (2011-2016)
Table United States Therapeutic Drug Monitoring Sales Market Share by Application (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Market Share by Application in 2015
Table United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
Figure United States Therapeutic Drug Monitoring Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Bio-Rad Laboratories Inc. Basic Information List
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2011-2016)
Table Danaher Corporation Therapeutic Drug Monitoring Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Drug Monitoring
Figure Manufacturing Process Analysis of Therapeutic Drug Monitoring
Figure Therapeutic Drug Monitoring Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2015
Table Major Buyers of Therapeutic Drug Monitoring
Table Distributors/Traders List
Figure United States Therapeutic Drug Monitoring Production and Growth Rate Forecast (2016-2021)
Figure United States Therapeutic Drug Monitoring Revenue and Growth Rate Forecast (2016-2021)
Table United States Therapeutic Drug Monitoring Production Forecast by Type (2016-2021)
Table United States Therapeutic Drug Monitoring Consumption Forecast by Application (2016-2021)
Table United States Therapeutic Drug Monitoring Sales Forecast by States (2016-2021)
Table United States Therapeutic Drug Monitoring Sales Share Forecast by States (2016-2021)